Granulocyte macrophage colony-stimulating factor is required for aortic dissection/intramural haematoma

Nature Communications

Volumn 6, Issue , 2015, Pages

  Son, Bo Kyung ^a   Sawaki, Daigo ^a   Tomida, Shota ^a   Fujita, Daishi ^a   Aizawa, Kenichi ^a,b   Aoki, Hiroki ^c   Akishita, Masahiro ^a   Manabe, Ichiro ^a   Komuro, Issei ^a   Friedman, Scott L ^d   Nagai, Ryozo ^b   Suzuki, Toru ^a,b,e,f  

^a UNIVERSITY OF TOKYO   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f Department of Cardiovascular Sciences University of Leicester Glenfield Hospital ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; KRUPPEL LIKE FACTOR 6; NEUTRALIZING ANTIBODY; COPEB PROTEIN, MOUSE; KRUPPEL LIKE FACTOR; ONCOPROTEIN;

ANTIBODY; BLOOD; DISEASE TREATMENT; GENE EXPRESSION; PHENOTYPE; PROTEIN; RODENT; WILD POPULATION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ANEURYSM; AORTA DISSECTION; ARTICLE; CELL INFILTRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOWN REGULATION; FLOW CYTOMETRY; GRANULOCYTE; HEMATOMA; HISTOPATHOLOGY; LYMPHOCYTE COUNT; MACROPHAGE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION; ADULT; AGED; ANEURYSM, DISSECTING; ANIMAL; AORTIC ANEURYSM; BLOOD; C57BL MOUSE; CASE CONTROL STUDY; FEMALE; GENETICS; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MIDDLE AGED; VERY ELDERLY;

MUS;

ADULT; AGED; AGED, 80 AND OVER; ANEURYSM, DISSECTING; ANIMALS; AORTIC ANEURYSM; CASE-CONTROL STUDIES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOMA; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; UP-REGULATION;

EID: 84928958215     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7994     Document Type: Article

References (51)

1. Nienaber, C. A. & Powell, J. T. Management of acute aortic syndromes. Eur. Heart J. 33, 26-35b (2012).
2. Tsai, T. T., Nienaber, C. A. & Eagle, K. A. Acute aortic syndromes. Circulation 112, 3802-3813 (2005).
3. Hiratzka, L. F. et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/ SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J. Am. Coll. Cardiol. 55, e27-e129 (2010).
4. Hagan, P. G. et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 283, 897-903 (2000).
5. Suzuki, T. et al. Biomarkers of aortic diseases. Am. Heart J. 165, 15-25 (2013).
6. Suzuki, T., Distante, A. & Eagle, K. Biomarker-assisted diagnosis of acute aortic dissection: how far we have come and what to expect. Curr. Opin. Cardiol. 25, 541-545 (2010).
7. Clough, R. E. & Nienaber, C. A. Management of acute aortic syndrome. Nat. Rev. Cardiol. 12, 103-114 (2014).
8. Song, J. K. Aortic intramural hematoma: aspects of pathogenesis 2011. Herz 36, 488-497 (2011).
9. von Kodolitsch, Y. et al. Intramural hematoma of the aorta: predictors of progression to dissection and rupture. Circulation 107, 1158-1163 (2003).
10. Milewicz, D. M., Regalado, E. S. & Guo, D. C. Treatment guidelines for thoracic aortic aneurysms and dissections based on the underlying causative gene. J. Thorac Cardiovasc. Surg. 140, S2-S4 discussion S45-51 (2010).
11. Milewicz, D. M. et al. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu. Rev. Genomics Hum. Genet. 9, 283-302 (2008).
12. Holm, T. M. et al. Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332, 358-361 (2011).
13. Li, W. et al. Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J. Clin. Invest. 124, 755-767 (2014).
14. Dietz, H. C. TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. J. Clin. Invest. 120, 403-407 (2010).
15. Ju, X. et al. Interleukin-6-signal transducer and activator of transcription-3 signaling mediates aortic dissections induced by angiotensin II via the T-helper lymphocyte 17-interleukin 17 axis in C57BL/6 mice. Arterioscler. Thromb. Vasc. Biol. 33, 1612-1621 (2013).
16. Tieu, B. C. et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J. Clin. Invest. 119, 3637-3651 (2009).
17. Date, D. et al. Kruppel-like transcription factor 6 regulates inflammatory macrophage polarization. J. Biol. Chem. 289, 10318-10329 (2014).
18. Starkel, P. et al. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J. Hepatol. 39, 538-546 (2003).
19. Holian, J. et al. Role of Kruppel-like factor 6 in transforming growth factorbeta1-induced epithelial-mesenchymal transition of proximal tubule cells. Am. J. Physiol. Renal Physiol. 295, F1388-F1396 (2008).
20. Hamilton, J. A. & Anderson, G. P. GM-CSF biology. Growth Factors 22, 225-231 (2004).
21. Daugherty, A., Manning, M. W. & Cassis, L. A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105, 1605-1612 (2000).
22. Johnston, K. W. et al. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J. Vasc. Surg. 13, 452-458 (1991).
23. Nagasawa, A. et al. Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms. J. Surg. Res. 183, 472-477 (2013).
24. Ezekowitz, R. A. & Gordon, S. Down-regulation of mannosyl receptormediated endocytosis and antigen F4/80 in bacillus Calmette-Guerin-activated mouse macrophages. Role of T lymphocytes and lymphokines. J. Exp. Med. 155, 1623-1637 (1982).
25. Ezekowitz, R. A., Austyn, J., Stahl, P. D. & Gordon, S. Surface properties of bacillus Calmette-Guerin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia. J. Exp. Med. 154, 60-76 (1981).
26. Atreya, R. et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat. Med. 6, 583-588 (2000).
27. Cheuk, B. L. & Cheng, S. W. Can local secretion of prostaglandin E2, thromboxane B2, and interleukin-6 play a role in ruptured abdominal aortic aneurysm? World J. Surg. 32, 55-61 (2008).
28. Dawson, J. et al. Aortic aneurysms secrete interleukin-6 into the circulation. J. Vasc. Surg. 45, 350-356 (2007).
29. Dawson, J., Cockerill, G., Choke, E., Loftus, I. & Thompson, M. M. Aortic aneurysms as a source of circulating interleukin-6. Ann. N. Y. Acad. Sci. 1085, 320-323 (2006).
30. Treska, V., Topolcan, O. & Pecen, L. Cytokines as plasma markers of abdominal aortic aneurysm. Clin. Chem. Lab. Med. 38, 1161-1164 (2000).
31. Wright, H. L., Moots, R. J., Bucknall, R. C. & Edwards, S. W. Neutrophil function in inflammation and inflammatory diseases. Rheumatology 49, 1618-1631 (2010).
32. Habashi, J. P. et al. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332, 361-365 (2011).
33. Lindsay, M. E. et al. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat. Genet. 44, 922-927 (2012).
34. Sawaki, D. & Suzuki, T. Targeting transforming growth factor-beta signaling in aortopathies in Marfan syndrome. Circ. J. 77, 898-899 (2013).
35. Feng, X. H. & Derynck, R. Specificity and versatility in tgf-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659-693 (2005).
36. Shindo, J. et al. Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable hyperlipidemic rabbits. Circulation 99, 2150-2156 (1999).
37. Zhu, S. N., Chen, M., Jongstra-Bilen, J. & Cybulsky, M. I. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J. Exp. Med. 206, 2141-2149 (2009).
38. Haghighat, A., Weiss, D., Whalin, M. K., Cowan, D. P. & Taylor, W. R. Granulocyte colony-stimulating factor and granulocyte macrophage colonystimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice. Circulation 115, 2049-2054 (2007).
39. Ye, P. et al. GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency. J. Clin. Invest. 123, 2317-2331 (2013).
40. Kimura, T. et al. Tenascin C protects aorta from acute dissection in mice. Sci. Rep. 4, 4051 (2014).
41. Weissen-Plenz, G. et al. Aortic dissection associated with Cogans's syndrome: deleterious loss of vascular structural integrity is associated with GM-CSF overstimulation in macrophages and smooth muscle cells. J. Cardiothorac. Surg. 5, 66 (2010).
42. Kessel, A., Vadasz, Z. & Toubi, E. Cogan syndrome-Pathogenesis, clinical variants and treatment approaches. Autoimmun. Rev. 13, 351-354 (2014).
43. Babamusta, F. et al. Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice. Atherosclerosis 186, 282-290 (2006).
44. Brocheriou, I. et al. Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: implication in atherosclerosis. Atherosclerosis 214, 316-324 (2011).
45. Filonzi, E. L., Zoellner, H., Stanton, H. & Hamilton, J. A. Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cells. Atherosclerosis 99, 241-252 (1993).
46. Sakai, M. et al. Glucocorticoid inhibits oxidized LDL-induced macrophage growth by suppressing the expression of granulocyte/macrophage colonystimulating factor. Arterioscler. Thromb. Vasc. Biol. 19, 1726-1733 (1999).
47. Plenz, G., Koenig, C., Severs, N. J. & Robenek, H. Smooth muscle cells express granulocyte-macrophage colony-stimulating factor in the undiseased and atherosclerotic human coronary artery. Arterioscler. Thromb. Vasc. Biol. 17, 2489-2499 (1997).
48. Saraff, K., Babamusta, F., Cassis, L. A. & Daugherty, A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23, 1621-1626 (2003).
49. Cavalcante, J. L., Lima, J. A., Redheuil, A. & Al-Mallah, M. H. Aortic stiffness: current understanding and future directions. J. Am. Coll. Cardiol. 57, 1511-1522 (2011).
50. Tarocchi, M. et al. Carcinogen-induced hepatic tumors in KLF6/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation. Hepatology 54, 522-531 (2011).
51. Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & Forster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277 (1999).